FOXC2 and cancer: Since we found that inhibition of FOXC2 changes the metabolism of cancer cells by promoting mitochondrial activity, future work is warranted to test whether combination treatment strategies can be employed to take advantage of altered metabolic states in cells that have features of EMT.